Mirum Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsMirum Pharmaceuticals

Mirum Pharmaceuticals(MIRM)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Livmarli	Maralixibat	2021-09-29	2031-2040	Pruritus , Alagille syndrome
Cholbam	Cholic acid	2015-03-17		Zellweger syndrome , Inborn errors metabolism

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

neurofibromatosis 1

,

neurofibromatoses

,

,

hyperlipidemias

,

central nervous system neoplasms

,

,

clostridium infections

,

colonic neoplasms

,

rectal neoplasms

,

,

hyperlipoproteinemia type iv

,

metabolic syndrome

,

hypertriglyceridemia

,

familial combined hyperlipidemia

,

liver function tests

,

,

alcoholic hepatitis

,

parkinson disease

,

huntington disease

,

cardiovascular diseases

,

,

,

alcoholic fatty liver

,

gastrointestinal diseases

,

digestive system diseases

,

liver neoplasms

,

,

,

rheumatoid arthritis

,

,

biliary tract diseases

,

barrett esophagus

,

,

cystic fibrosis

,

,

muscle spasticity

,

hereditary spastic paraplegia

,

,

irritable bowel syndrome

,

,

cardiomyopathies

,

disease progression

,

,

neoplasm metastasis

,

radiation injuries

,

,

insulin resistance

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

,

,

x-linked genetic diseases

,

smith-lemli-opitz syndrome

,

,

,

,

bile duct diseases

,

adolescent development

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

obstructive jaundice

,

,

esophageal neoplasms

,

head and neck neoplasms

,

end stage liver disease

,

,

,

breast neoplasms

,

,

healthy volunteers/patients

,

intrahepatic cholestasis

,

colorectal neoplasms

,

cerebrotendinous xanthomatosis

,

,

,

,

pregnancy complications

,

glucose intolerance

,

sclerosing cholangitis

,

peroxisomal disorders

,

zellweger syndrome

,

infantile refsum disease

,

adrenoleukodystrophy

,

,

,

adenomatous polyposis coli

,

nasopharyngeal neoplasms

,

,

,

retinal detachment

,

dissociative disorders

,

chronic hepatitis c

,

duodenal neoplasms

,

inborn errors metabolism

,

inborn errors lipid metabolism

,

inborn errors steroid metabolism

,

,

inborn genetic diseases

,

,

child nutrition disorders

,

ulcerative colitis

,

,

,

thyroid diseases

,

,

chronic hepatitis

,

acute cholecystitis

,

,

acalculous cholecystitis

,

,

,

biliary liver cirrhosis

,

,

,

,

liver cirrhosis

,

non-alcoholic fatty liver disease

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

,

cholecystolithiasis

,

,

,

,

,

chemical and drug induced liver injury

,

,

hyperbilirubinemia

,

gestational diabetes

,

,

autoimmune hepatitis

,

,

,

neonatal hyperbilirubinemia

,

malabsorption syndromes

,

lipid metabolism disorders

,

,

,

hemolytic anemia

,

chronic kidney failure

,

kidney diseases

,

short bowel syndrome

,

cardiac surgical procedures

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

fontan procedure

,

,

communicable diseases

,

,

brain neoplasms

,

,

germ cell and embryonal neoplasms

,

medulloblastoma

,

,

,

,

rhabdomyosarcoma

,

primitive neuroectodermal tumors

,

,

retinal neoplasms

,

neuroectodermal tumors

,

phenylketonurias

,

appetite regulation

,

,

liver transplantation

,

reperfusion injury

,

gastroesophageal reflux

,

,

biliary atresia

,

liver regeneration

,

,

hepatocellular carcinoma

,

cholangiocarcinoma

,

wounds and injuries

,

cerebrotendinous xanthomatosis

,

,

healthy volunteers/patients

,

alagille syndrome

,

,

biliary liver cirrhosis

,

substance withdrawal syndrome

,

biliary atresia

,

sclerosing cholangitis

,

,

,

intrahepatic cholestasis

,

Maralixibat chloride

,

healthy volunteers/patients

,

biliary liver cirrhosis

,

substance withdrawal syndrome

,

biliary atresia

,

sclerosing cholangitis

,

alagille syndrome

,

,

,

,

intrahepatic cholestasis

,

,

,

cystic fibrosis

,

,

healthy volunteers/patients

,

non-alcoholic fatty liver disease

,

,

alcoholic fatty liver

,

,

,

pregnancy complications

,

intrahepatic cholestasis

,

sclerosing cholangitis

,

biliary liver cirrhosis

,

digestive system diseases

,

cocaine-related disorders

,

muscular atrophy

,

spinal muscular atrophy

,

,

,

lambert-eaton myasthenic syndrome

,

myasthenia gravis

,

congenital myasthenic syndromes

,

muscle weakness

,

healthy volunteers/patients

,

non-alcoholic fatty liver disease

,

,

alcoholic fatty liver

,

,

,

pregnancy complications

,

intrahepatic cholestasis

,

sclerosing cholangitis

,

biliary liver cirrhosis

,

digestive system diseases

,

Histone-arginine methyltransferase carm1

neuroendocrine tumors

neuroendocrine tumors

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use